United States - English - NLM (National Library of Medicine)

american health packaging - pyridostigmine bromide (unii: kvi301na53) (pyridostigmine - unii:19qm69hh21) - pyridostigmine bromide 60 mg - pyridostigmine bromide tablets are useful in the treatment of myasthenia gravis. pyridostigmine bromide is contraindicated in mechanical intestinal or urinary obstruction, and particular caution should be used in its administration to patients with bronchial asthma. care should be observed in the use of atropine for counteracting side effects, as discussed below.

United States - English - NLM (National Library of Medicine)

major pharmaceuticals - pyridostigmine bromide (unii: kvi301na53) (pyridostigmine - unii:19qm69hh21) - pyridostigmine bromide 60 mg - pyridostigmine bromide tablets, usp are useful in the treatment of myasthenia gravis. pyridostigmine bromide tablets, usp are contraindicated in mechanical intestinal or urinary obstruction, and particular caution should be used in its administration to patients with bronchial asthma. care should be observed in the use of atropine for counteracting side effects, as discussed below.

United States - English - NLM (National Library of Medicine)

oceanside pharmaceuticals - pyridostigmine bromide (unii: kvi301na53) (pyridostigmine - unii:19qm69hh21) - pyridostigmine bromide 60 mg - pyridostigmine bromide tablets are contraindicated in mechanical intestinal or urinary obstruction, and particular caution should be used in its administration to patients with bronchial asthma. care should be observed in the use of atropine for counteracting side effects, as discussed below.

United States - English - NLM (National Library of Medicine)

alvogen, inc. - pyridostigmine bromide (unii: kvi301na53) (pyridostigmine - unii:19qm69hh21) - pyridostigmine bromide 180 mg - pyridostigmine bromide extended release tablets is contraindicated in mechanical intestinal or urinary obstruction, and particular caution should be used in its administration to patients with bronchial asthma. care should be observed in the use of atropine for counteracting side effects, as discussed below.

United States - English - NLM (National Library of Medicine)

zydus pharmaceuticals (usa) inc. - pyridostigmine bromide (unii: kvi301na53) (pyridostigmine - unii:19qm69hh21) - pyridostigmine bromide 60 mg - pyridostigmine bromide tablets, usp are useful in the treatment of myasthenia gravis. pyridostigmine bromide tablets, usp are contraindicated in mechanical intestinal or urinary obstruction, and particular caution should be used in its administration to patients with bronchial asthma. care should be observed in the use of atropine for counteracting side effects, as discussed below.

United States - English - NLM (National Library of Medicine)

zydus lifesciences limited - pyridostigmine bromide (unii: kvi301na53) (pyridostigmine - unii:19qm69hh21) - pyridostigmine bromide 60 mg - pyridostigmine bromide tablets, usp are useful in the treatment of myasthenia gravis. pyridostigmine bromide tablets, usp are contraindicated in mechanical intestinal or urinary obstruction, and particular caution should be used in its administration to patients with bronchial asthma. care should be observed in the use of atropine for counteracting side effects, as discussed below.

United States - English - NLM (National Library of Medicine)

amneal pharmaceuticals of new york llc - pyridostigmine bromide (unii: kvi301na53) (pyridostigmine - unii:19qm69hh21) - pyridostigmine bromide 180 mg - pyridostigmine bromide is useful in the treatment of myasthenia gravis. pyridostigmine bromide is contraindicated in mechanical intestinal or urinary obstruction, and particular caution should be used in its administration to patients with bronchial asthma. care should be observed in the use of atropine for counteracting side effects, as discussed below.

United States - English - NLM (National Library of Medicine)

oceanside pharmaceuticals - pyridostigmine bromide (unii: kvi301na53) (pyridostigmine - unii:19qm69hh21) - pyridostigmine bromide 180 mg - pyridostigmine bromide extended-release tablets are contraindicated in mechanical intestinal or urinary obstruction, and particular caution should be used in its administration to patients with bronchial asthma. care should be observed in the use of atropine for counteracting side effects, as discussed below.

United States - English - NLM (National Library of Medicine)

amneal pharmaceuticals of new york llc - pyridostigmine bromide (unii: kvi301na53) (pyridostigmine - unii:19qm69hh21) - pyridostigmine bromide 60 mg - pyridostigmine bromide tablets are useful in the treatment of myasthenia gravis. pyridostigmine bromide is contraindicated in mechanical intestinal or urinary obstruction, and particular caution should be used in its administration to patients with bronchial asthma. care should be observed in the use of atropine for counteracting side effects, as discussed below.

United States - English - NLM (National Library of Medicine)

valeant canada limited - pyridostigmine bromide (unii: kvi301na53) (pyridostigmine - unii:19qm69hh21) - tablet - 30 mg - pyridostigmine bromide is indicated for pretreatment against the lethal effects of soman nerve agent poisoning. pyridostigmine is intended for use in conjunction with protective garments, including a mask. at the first sign of nerve agent poisoning, pyridostigmine should be stopped, and atropine and pralidoxime therapy started immediately. the evidence for the effectiveness of pyridostigmine as pretreatment against soman-induced toxicity was derived from animal studies alone [see nonclinical toxicology (13.2) ]. for military medical use only - mechanical intestinal or urinary obstruction - known hypersensitivity to anticholinesterase agents pregnancy category b pyridostigmine produced no teratogenic effects in rats given up to 30 mg/kg/day and in rabbits given up to 45 mg/kg/day orally during the period of organogenesis. these doses are 3 and 10 times, respectively, the recommended human dose of 90 mg on a mg/m2 basis. in rats, a slight degree of delayed skeletal ossification was seen at 30 mg/kg, a dose wh